Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 2 | 2023 | 195 | 1.260 |
Why?
|
| Models, Biological | 4 | 2013 | 712 | 1.050 |
Why?
|
| Buprenorphine | 1 | 2023 | 51 | 0.790 |
Why?
|
| Melanoma | 1 | 2023 | 110 | 0.720 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 178 | 0.690 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 226 | 0.630 |
Why?
|
| Proportional Hazards Models | 4 | 2023 | 518 | 0.540 |
Why?
|
| HIV Infections | 5 | 2022 | 2586 | 0.510 |
Why?
|
| Humans | 26 | 2025 | 43102 | 0.410 |
Why?
|
| Phytoplankton | 1 | 2013 | 5 | 0.400 |
Why?
|
| Anti-HIV Agents | 3 | 2021 | 486 | 0.360 |
Why?
|
| Particulate Matter | 2 | 2025 | 83 | 0.360 |
Why?
|
| Education, Medical | 2 | 2023 | 118 | 0.350 |
Why?
|
| Air Pollutants | 2 | 2025 | 130 | 0.340 |
Why?
|
| United States | 6 | 2023 | 5205 | 0.340 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 12 | 0.330 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 252 | 0.330 |
Why?
|
| Tennessee | 4 | 2025 | 93 | 0.330 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 55 | 0.320 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 367 | 0.310 |
Why?
|
| SEER Program | 2 | 2023 | 164 | 0.290 |
Why?
|
| Students, Medical | 2 | 2021 | 158 | 0.270 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 48 | 0.260 |
Why?
|
| Glioma | 1 | 2007 | 96 | 0.250 |
Why?
|
| Vaccination | 2 | 2025 | 355 | 0.240 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 140 | 0.240 |
Why?
|
| Poliomyelitis | 1 | 2005 | 7 | 0.230 |
Why?
|
| Spheroids, Cellular | 1 | 2005 | 37 | 0.220 |
Why?
|
| Environmental Exposure | 2 | 2025 | 256 | 0.220 |
Why?
|
| Neoplasms | 2 | 2013 | 1377 | 0.220 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2025 | 117 | 0.210 |
Why?
|
| Female | 13 | 2025 | 24698 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2021 | 408 | 0.200 |
Why?
|
| Mathematical Concepts | 2 | 2013 | 9 | 0.200 |
Why?
|
| Population Dynamics | 2 | 2013 | 50 | 0.200 |
Why?
|
| Systems Biology | 2 | 2013 | 27 | 0.200 |
Why?
|
| Nutrition Therapy | 1 | 2022 | 10 | 0.190 |
Why?
|
| Naloxone | 1 | 2023 | 56 | 0.190 |
Why?
|
| Models, Statistical | 2 | 2014 | 195 | 0.190 |
Why?
|
| Papillomavirus Vaccines | 1 | 2025 | 174 | 0.180 |
Why?
|
| Skin | 1 | 2023 | 187 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 749 | 0.180 |
Why?
|
| Gastric Emptying | 1 | 2021 | 14 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1723 | 0.170 |
Why?
|
| Cell Proliferation | 4 | 2013 | 1455 | 0.170 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 11 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 376 | 0.160 |
Why?
|
| Pressure | 1 | 2020 | 50 | 0.160 |
Why?
|
| Primary Health Care | 1 | 2023 | 380 | 0.160 |
Why?
|
| Students, Dental | 1 | 2019 | 7 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 706 | 0.150 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 44 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 131 | 0.150 |
Why?
|
| Air Pollution | 1 | 2020 | 87 | 0.150 |
Why?
|
| Benzo(a)pyrene | 1 | 2020 | 128 | 0.150 |
Why?
|
| Treatment Outcome | 1 | 2023 | 1604 | 0.150 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 182 | 0.150 |
Why?
|
| Medication Adherence | 1 | 2021 | 182 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2023 | 2544 | 0.150 |
Why?
|
| Students, Nursing | 1 | 2019 | 38 | 0.150 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 280 | 0.150 |
Why?
|
| Prejudice | 1 | 2019 | 116 | 0.140 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 129 | 0.140 |
Why?
|
| Physicians | 1 | 2021 | 188 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 148 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 223 | 0.140 |
Why?
|
| Antioxidants | 1 | 2021 | 443 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 231 | 0.130 |
Why?
|
| Liver | 1 | 2020 | 511 | 0.130 |
Why?
|
| Saliva | 1 | 2017 | 119 | 0.120 |
Why?
|
| Male | 7 | 2025 | 23409 | 0.120 |
Why?
|
| Appalachian Region | 1 | 2014 | 6 | 0.110 |
Why?
|
| Southeastern United States | 1 | 2014 | 64 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2014 | 83 | 0.110 |
Why?
|
| Logistic Models | 2 | 2017 | 1009 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2014 | 121 | 0.110 |
Why?
|
| Algorithms | 2 | 2014 | 509 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 375 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 35 | 0.100 |
Why?
|
| Risk Factors | 4 | 2020 | 3994 | 0.100 |
Why?
|
| Biomass | 1 | 2013 | 68 | 0.100 |
Why?
|
| Mortality | 1 | 2014 | 175 | 0.100 |
Why?
|
| Texas | 1 | 2014 | 457 | 0.090 |
Why?
|
| Light | 1 | 2013 | 185 | 0.090 |
Why?
|
| RNA Interference | 1 | 2013 | 247 | 0.090 |
Why?
|
| Temperature | 1 | 2013 | 313 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 368 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 638 | 0.090 |
Why?
|
| Adult | 5 | 2025 | 13872 | 0.090 |
Why?
|
| Iodoacetates | 1 | 2010 | 2 | 0.080 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2010 | 15 | 0.080 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 2010 | 20 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 173 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 72 | 0.080 |
Why?
|
| Prognosis | 1 | 2012 | 861 | 0.080 |
Why?
|
| Schools, Medical | 2 | 2023 | 208 | 0.080 |
Why?
|
| Middle Aged | 5 | 2025 | 12222 | 0.080 |
Why?
|
| Animals | 5 | 2025 | 16992 | 0.080 |
Why?
|
| Viral Load | 2 | 2021 | 348 | 0.070 |
Why?
|
| Young Adult | 3 | 2025 | 5080 | 0.070 |
Why?
|
| Adolescent | 3 | 2025 | 6081 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 1596 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 968 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2021 | 760 | 0.060 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2025 | 3 | 0.060 |
Why?
|
| Influenza Vaccines | 1 | 2025 | 58 | 0.060 |
Why?
|
| Prenatal Care | 1 | 2025 | 93 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 508 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 61 | 0.050 |
Why?
|
| Health Status Disparities | 2 | 2020 | 719 | 0.050 |
Why?
|
| Rural Population | 1 | 2025 | 373 | 0.040 |
Why?
|
| Pyloric Antrum | 1 | 2021 | 6 | 0.040 |
Why?
|
| Educational Status | 1 | 2023 | 339 | 0.040 |
Why?
|
| Community Health Services | 1 | 2023 | 206 | 0.040 |
Why?
|
| Self Care | 1 | 2022 | 175 | 0.040 |
Why?
|
| Acrolein | 1 | 2021 | 17 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2021 | 57 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3156 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 389 | 0.040 |
Why?
|
| Porosity | 1 | 2020 | 43 | 0.040 |
Why?
|
| Bisexuality | 1 | 2023 | 211 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2021 | 93 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 1772 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 139 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2020 | 57 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2020 | 169 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 118 | 0.040 |
Why?
|
| Solvents | 1 | 2020 | 113 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 92 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 68 | 0.040 |
Why?
|
| Curcumin | 1 | 2021 | 118 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2019 | 139 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 989 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2021 | 386 | 0.030 |
Why?
|
| Water | 1 | 2020 | 316 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 701 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2019 | 195 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1035 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 458 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1759 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 6644 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 486 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2021 | 2157 | 0.020 |
Why?
|
| Refractive Errors | 1 | 2010 | 28 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 232 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 667 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 8214 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2676 | 0.010 |
Why?
|